Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (39)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Collin, G. B.
Right arrow Articles by Nishina, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collin, G. B.
Right arrow Articles by Nishina, P. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 6, 213-219, Copyright © 1997 by Oxford University Press


ARTICLES

Homozygosity mapping at Alstrom syndrome to chromosome 2p

GB Collin, JD Marshall, LR Cardon and PM Nishina
Jackson Laboratory, Bar Harbor, ME 04609-1500, USA.

Alstrom syndrome is a rare autosomal recessive disorder characterized by pigmentary retinal degeneration, sensorineural hearing loss, childhood obesity, non-insulin-dependent diabetes mellitus, hyperlipidemia and chronic nephropathy. Features occasionally observed include acanthosis nigricans, hypogonadism, hypothyroidism, alopecia, short stature and cardiomyopathy. We report here the results of a linkage study in a large French Acadian kindred, as a first step in identifying the molecular basis of Alstrom syndrome. Evidence of a founder effect made if feasible to use a homozygosity mapping strategy to identify the chromosomal location of the Alstrom gene. In a genome- wide screen, haplotype sharing for a region on chromosome 2 was observed in all affected individuals. Two point linkage analysis resulted in a maximum lod score of 3.84 (theta = 0.00) for marker D2S292. By testing additional markers, the disease gene was localized to a 14.9 cM region on chromosome 2p.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch OphthalmolHome page
E. Malm, V. Ponjavic, P. M. Nishina, J. K. Naggert, E. G. Hinman, S. Andreasson, J. D. Marshall, and C. Moller
Full-Field Electroretinography and Marked Variability in Clinical Phenotype of Alstrom Syndrome
Arch Ophthalmol, January 1, 2008; 126(1): 51 - 57.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Arsov, D. G. Silva, M. K. O'Bryan, A. Sainsbury, N. J. Lee, C. Kennedy, S. S.M. Manji, K. Nelms, C. Liu, C. G. Vinuesa, et al.
Fat Aussie--A New Alstrom Syndrome Mouse Showing a Critical Role for ALMS1 in Obesity, Diabetes, and Spermatogenesis
Mol. Endocrinol., July 1, 2006; 20(7): 1610 - 1622.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J Bond, K Flintoff, J Higgins, S Scott, C Bennet, J Parsons, J Mannon, H Jafri, Y Rashid, M Barrow, et al.
The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy
J. Med. Genet., February 1, 2005; 42(2): e10 - e10.
[Full Text] [PDF]


Home page
J. Cell Sci.Home page
E. Nili, G. S. Cojocaru, Y. Kalma, D. Ginsberg, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, R. Berger, S. Shaklai, N. Amariglio, et al.
Nuclear membrane protein LAP2{beta} mediates transcriptional repression alone and together with its binding partner GCL (germ-cell-less)
J. Cell Sci., March 11, 2002; 114(18): 3297 - 3307.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
U. ZUMSTEG, P. Y MULLER, and A. R MISEREZ
Alstrom syndrome: confirmation of linkage to chromosome 2p12-13 and phenotypic heterogeneity in three affected sibs
J. Med. Genet., July 1, 2000; 37(7): 8e - 8.
[Full Text]


Home page
CirculationHome page
J. Schonberger, H. Levy, E. Grunig, S. Sangwatanaroj, D. Fatkin, C. MacRae, H. Stacker, C. Halpin, R. Eavey, E. F. Philbin, et al.
Dilated Cardiomyopathy and Sensorineural Hearing Loss : A Heritable Syndrome That Maps to 6q23-24
Circulation, April 18, 2000; 101(15): 1812 - 1818.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
V. J. DEEBLE, E. ROBERTS, A. JACKSON, N. LENCH, G. KARBANI, and C. G. WOODS
The continuing failure to recognise Alstrom syndrome and further evidence of genetic homogeneity
J. Med. Genet., March 1, 2000; 37(3): 219 - 219.
[Full Text]


Home page
J. Med. Genet.Home page
P L Beales, N Elcioglu, A S Woolf, D Parker, and F A Flinter
New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey
J. Med. Genet., June 1, 1999; 36(6): 437 - 446.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. A. Encinas, K. Kikuchi, A. Chedotal, F. de Castro, C. S. Goodman, and T. Kimura
Cloning, expression, and genetic mapping of Sema W, a member of the semaphorin family
PNAS, March 2, 1999; 96(5): 2491 - 2496.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.